THE PERCENT OF DOCTOR’S OFFICE VISITS DRIVEN BY FLU LIKE SYMPTOMS LAST WEEK WAS HIGHER THAN THE PEAK OF ANY WINTER FLU SEASON SINCE 2009 TO 2010. SO FAR THIS SEASON, THE CDC ESTIMATES THERE HAVE BEEN ...

Lawsuit comes after Friday's announcement that the NIH would limit the indirect costs it will pay grantees to 15 percent of a ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

A small but growing number of house cats have gotten sick from H5N1, the bird flu strain driving the current U.S. outbreak.

SpringWorks Therapeutics shares rose 36% after Reuters reported Germany's Merck KGaA is in advanced talks to buy the company. Shares were trading around $54.66. The stock is up 16% over the last year ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Ms. Zaidat Ibrahim is a PhD candidate at Indiana University. Ibrahim holds a Master of Public Health degree from the University ...

-- Germany's Merck KGaA is in advanced talks to buy U.S. cancer and rare diseases biotech company Springworks Therapeutics, Reuters says, citing unnamed sources. -- The deal could be finalized in the ...

Springworks, which listed its shares in New York in 2019, is a commercial-stage biotech firm that develops drugs to treat various forms of cancer and other rare diseases such as uterine cancer and ...

GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the testing common at birth. The goal: Identify potential diseases or conditions so ...